(musk xylene) 二甲苯麝香 Perfume, cosmetics 香水,化妆品 81-15-2 10 11 12 Bis(2-ethyl(hexyl)phthalate) (DEHP) 邻苯二甲酸二(2-乙基己)脂 Hexabromocyclododecane (HBCDD) and all major Diastereoisomers identified :六溴环十二烷(HBCDD)以及所有 主要的非對應異構體 a-HBCDD,b- HBCDD,y-HBCDD) ...
Until October 1, 2010, we were a “shell company,” as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended. We were originally formed as a Texas corporation on March 21, 2003 to acquire most of the assets and certain liabilities of and succeed to...
In March 2010, the Company purchased a patent from Shandong YCT for US$6.74 million, which enabled the Company to manufacture and distribute medicine products for cardio cerebral vascular disease, cosmetics and healthcare products. The purchase price for the patent was determined through negotiations ...
See the definitions of “large accelerated filer,”“accelerated filer,”“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ (Do not check if a smaller reporting company) ...
Until October 1, 2010, we were a “shell company,” as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended. We were originally formed as a Texas corporation on March 21, 2003 to acquire most of the assets and certain liabilities of and succeed to...
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has bee...
Until October 1, 2010, we were a “shell company,” as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended. We were originally formed as a Texas corporation on March 21, 2003 to acquire most of the assets and certain liabilities of and succeed to...
handle a wide range of materials and formulations, from aqueous solutions to volatile organic solvents (limited to glass-based microfluidics), viscous polymers, nanoparticles [20,33,34], and sensitive biological entities like genetic material [22,35], enzymes [36,37], and even cells [22,23,35...